International conference on multiple myeloma : biology, pathophysiology prognosis and treatment, June 19-22, 1989, Bologna, ItalyTURA, Sante; CAVO, Michele; GOBBI, Marco et al.European journal of haematology. Supplementum. 1989, Vol 51, issn 0902-4506, 195 p.Conference Proceedings

Use of surface plasmon resonance to study the elongation kinetics and the binding properties of the highly amyloidogenic Aβ_1―42 peptide, synthesized by depsi-peptide techniqueSTRAVALACI, Matteo; BEEG, Marten; SALMONA, Mario et al.Biosensors & bioelectronics. 2011, Vol 26, Num 5, pp 2772-2775, issn 0956-5663, 4 p.Article

Genetic haemochromatosis: genes and mutations associated with iron loadingCAMASCHELLA, Clara; ROETTO, Antonella; DE GOBBI, Marco et al.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 2, pp 261-276, issn 1521-6926, 16 p.Article

Juvenile hemochromatosisCAMASCHELLA, Clara; ROETTO, Antonella; DE GOBBI, Marco et al.Seminars in hematology. 2002, Vol 39, Num 4, pp 242-248, issn 0037-1963, 7 p.Article

Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1FUMAGALLI, Elena; FUNICELLO, Marcella; RAUEN, Thomas et al.European journal of pharmacology. 2008, Vol 578, Num 2-3, pp 171-176, issn 0014-2999, 6 p.Article

Clinical study of the novel cyclin-dependent kinase inhibitor dinaciclib in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia patientsFABRE, Claire; GOBBI, Marco; LE TOURNEAU, Christophe et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 5, pp 1057-1064, issn 0344-5704, 8 p.Article

New insights into the molecular mechanisms underlying sensitivity/resistance to the atypical retinoid ST1926 in acute myeloid leukaemia cells: The role of histone H2A.Z, cAMP-dependent protein kinase A and the proteasomeFRATELLI, Maddalena; FISHER, James Neil; GIANNI, Maurizio et al.European journal of cancer (1990). 2013, Vol 49, Num 6, pp 1491-1500, issn 0959-8049, 10 p.Article

Charge and spin transport in PEDOT:PSS nanoscale lateral devicesDE OLIVEIRA, Thales V. A. G; GOBBI, Marco; PORRO, José M et al.Nanotechnology (Bristol. Print). 2013, Vol 24, Num 47, issn 0957-4484, 475201.1-475201.10Article

Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behaviorFORCONI, Francesco; SOZZI, Elisa; GALLAMINI, Andrea et al.Blood. 2009, Vol 114, Num 21, pp 4696-4702, issn 0006-4971, 7 p.Article

N.N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currentsGOBBI, Marco; FUNICELLO, Marcella; REYES-PARADA, Miguel et al.Journal of neurochemistry. 2008, Vol 105, Num 5, pp 1770-1780, issn 0022-3042, 11 p.Article

Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphomaZINZANI, Pier Luigi; PULSONI, Alessandro; TUCCI, Alessandra et al.Journal of clinical oncology. 2004, Vol 22, Num 13, pp 2654-2661, issn 0732-183X, 8 p.Article

A Recessive Mutation in the APP Gene with Dominant-Negative Effect on AmyloidogenesisDI FEDE, Giuseppe; CATANIA, Marcella; FALCONE, Chiara et al.Science (Washington, D.C.). 2009, Vol 323, Num 5920, pp 1473-1477, issn 0036-8075, 5 p.Article

The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathwaysDE TOTERO, Daniela; MEAZZA, Raffaella; CAPAIA, Matteo et al.Blood. 2008, Vol 111, Num 2, pp 517-524, issn 0006-4971, 8 p.Article

Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant : A feasible and effective salvage treatment for lymphoid malignanciesCLAVIO, Marino; GARRONE, Alberto; CANEPA, Letizia et al.Oncology reports. 2005, Vol 14, Num 4, pp 933-940, issn 1021-335X, 8 p.Article

Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapyCALETTI, Giancarlo; TOGLIANI, Thomas; FUSAROLI, Pietro et al.Gastroenterology (New York, NY. 1943). 2003, Vol 124, Num 2, pp 537-543, issn 0016-5085, 7 p.Article

CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-α and interferon-γ and tumor necrosis factor receptor-I-II upregulationDE TOTERO, Daniela; TAZZARI, Pier Luigi; CAPAIA, Matteo et al.Haematologica (Roma). 2003, Vol 88, Num 2, pp 148-158, issn 0390-6078, 11 p.Article

Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myelomaBALLESTRERO, Alberto; FERRANDO, Fabio; PATRONE, Franco et al.European journal of haematology. 2002, Vol 68, Num 2, pp 101-106, issn 0902-4441Article

New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase InhibitorsCEA, Michele; CAGNETTA, Antonia; GOBBI, Marco et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 4, pp 734-744, issn 1381-6128, 11 p.Article

New Method Based on Capillary Electrophoresis with Laser-Induced Fluorescence Detection (CE-LIF) to Monitor Interaction between Nanoparticles and the Amyloid-β PeptideBRAMBILIA, Davide; VERPILLOT, Romain; NICOLAS, Valérie et al.Analytical chemistry (Washington). 2010, Vol 82, Num 24, pp 10083-10089, issn 0003-2700, 7 p.Article

Synthesis of new β- and γ-benzyloxy-S-glutamic acid derivatives and evaluation of their activity as inhibitors of excitatory amino acid transportersTAMBORINI, Lucia; CONTI, Paola; PINTO, Andrea et al.Tetrahedron (Oxford. Print). 2009, Vol 65, Num 31, issn 0040-4020, 5871, 6083-6089 [8 p.]Article

Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemiaLE COUTRE, Philipp; OTTMANN, Oliver G; KULICZKOWSKI, Kazimierz et al.Blood. 2008, Vol 111, Num 4, pp 1834-1839, issn 0006-4971, 6 p.Article

Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia : results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patientsCLAVIO, Marino; VIGNOLO, Luana; BALLEARI, Enrico et al.British journal of haematology. 2007, Vol 138, Num 2, pp 186-195, issn 0007-1048, 10 p.Article

Comparison between patients with philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatmentIACOBUCCI, Ilaria; ROSTI, Gianantonio; IULIANO, Francesco et al.Journal of clinical oncology. 2006, Vol 24, Num 3, pp 454-459, issn 0732-183X, 6 p.Article

Structure-affinity studies for a novel series of homochiral naphtho and tetrahydronaphtho analogues of α₁ antagonist WB-4101BOLCHI, Cristiano; CATALANO, Paolo; FUMAGALLI, Laura et al.Bioorganic & medicinal chemistry. 2004, Vol 12, Num 18, pp 4937-4951, issn 0968-0896, 15 p.Article

Vδ1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acidPOGGI, Alessandro; VENTURINO, Claudia; ZOCCHI, Maria Raffaella et al.Cancer research (Baltimore). 2004, Vol 64, Num 24, pp 9172-9179, issn 0008-5472, 8 p.Article